Literature DB >> 22108487

Ocular and optic nerve ischemia: recognition and treatment with intravenous prostaglandin E1.

R D Steigerwalt1, M R Cesarone, A Pascarella, M De Angelis, M Nebbioso, G Belcaro, B Feragalli.   

Abstract

Ischemia of the optic nerve, the retina and the choroid are common problems in ophthalmology. This paper presents the different types of ischemia and their treatment with prostaglandin E1 (PGE1), a powerful vasodilator of the microcirculation. This is a review article of various previously published case reports and studies presenting patients with different types of ocular and optic nerve ischemia. Their treatment with intravenous (IV) PGE1 is described. Treatment for acute and chronic problems is presented. The visual acuity and/or the visual fields improved in almost all the treated patients. When measured, the blood flow velocities also improved. No complications due to the use of PGE1 were seen. Treatment with IV PGE1 should be considered in cases of ocular and optic nerve ischemia to immediately restore blood flow to these structures and improve the visual acuity. Intravenous prostaglandin E1 is an effective treatment for ocular and optic nerve ischemia leading to immediate visual improvement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108487

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  2 in total

1.  Periarteriolar-Sparing Retinal Edema in Acute Central Retinal Artery Occlusion.

Authors:  Yoshifumi Ikeda; Ichiya Sano; Etsuko Fujihara; Masaki Tanito
Journal:  Case Rep Ophthalmol       Date:  2015-11-27

Review 2.  Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.

Authors:  Raquel Boia; Noelia Ruzafa; Inês Dinis Aires; Xandra Pereiro; António Francisco Ambrósio; Elena Vecino; Ana Raquel Santiago
Journal:  Int J Mol Sci       Date:  2020-03-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.